CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
30818-18-9 | 2-[2,4-双(1,1-二甲基丙基)苯氧基]-N-[4-[4,5-二氢-5-氧代-4-[(1-苯基-1H-四唑-5-基)硫]-3-吡咯烷基]-1H-吡 | 2-(2,4-Bis(1,1-dimethylpropyl)phenoxy)-N-(4-(4,5-dihydro-5-oxo-4-((1-phenyl-1H-tetrazol-5-yl)thio)-3; Butyranilide,2-(2,4-di-tert-pentylphenoxy)-4'-[5-oxo-4-[(1-phenyl-1H-tetrazol-5-yl)thio]-3-(1-pyrrolidinyl)-2-pyrazolin-1-yl]-(8CI) | C40H50N8O3S | 详情 | 供应商 | |
56796-20-4 | 头孢美唑; (6R-cis)-7-[[[(氰甲基)硫]乙酰]氨基]-7-甲氧基-3-[[(1-甲基-1H-四唑-5-基)硫]甲基]-8-氧代-5-硫? | Cefmetazole; (6R-cis)-7-[[[(Cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | C15H17N7O5S3 | 详情 | 供应商 | |
61270-71-1 | (6R-反式)-7-氨基-8-氧代-3-(((1-(磺酸甲基)-1H-四唑-5-基)硫)甲基)-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧 | (6R-trans)-7-Amino-8-oxo-3-(((1-(sulphomethyl)-1H-tetrazol-5-yl)thio)methyl)-5-thia-1-azabicyclo[4.2; 7-ACA-3-SMT | C10H12N6O6S3 | 详情 | 供应商 | |
64952-97-2 | 拉氧头孢; 7-((羧基(4-羟基苯基)乙酰)氨基)-7-甲氧基-(3-((1-甲基-1H-四唑-5-基)硫)甲基)-8-氧代-5-氧杂-1-? | Latamoxef; 7-((Carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-(3-((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | C20H20N6O9S | 详情 | 供应商 | |
64953-12-4 | 拉氧头孢钠; 7-[[羧基(4-羟基苯基)乙酰]氨基]-7-甲氧基-3-[[(1-甲基-1H-四唑-5-基)硫]甲基]-8-氧代-5-氧杂-1 | Latamoxef sodium; Moxalactam sodium salt; Disodium 7-[[carboxylato(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | C20H18N6Na2O9S | 详情 | 供应商 | |
65085-01-0 | 头孢甲肟; (6R,7R)-7-[2-(2-氨基-4-噻唑基)-2-(甲氧亚氨基)乙酰氨基]-3-[[(1-甲基-1H-四唑-5-基)-硫]甲基]-8 | Cefmenoxime; (6R-(6alpha,7beta(Z)))-7-(((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid | C16H17N9O5S3 | 详情 | 供应商 | |
70035-75-5 | (6R,7S)-7-[(溴乙酰)氨基]-7-甲氧基-3-[[(1-甲基-1H-四唑-5-基)硫]甲基]-8-氧代-5-硫杂-1-氮杂双环[4.2.0]? | 7-BMAC; (6R,7S)-7-[(Bromoacetyl)amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenylmethyl ester | C26H25BrN6O5S2 | 详情 | 供应商 | |
92823-03-5 | 氟氧头孢钠; (6R,7R)-7-(2-((二氟甲基)硫)乙酰氨基)-3-(((1-(2-羟乙基)-1H-四唑-5-基)硫)甲基)-7-甲氧基-8-? | Flomoxef sodium; (6R,7R)-7-(2-((Difluoromethyl)thio)acetamido)-3-(((1-(2-hydroxyethyl)-1H-tetrazol-5-yl)thio)methyl)-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt | C15H17F2N6NaO7S2 | 详情 | 供应商 | |
99665-00-6 | 氟氧头孢; (-)-(6R,7R)-7-(2-((二氟甲基)硫)乙酰氨基)-3-(((1-(2-羟乙基)-1H-四唑-5-基)硫)甲基)-7-甲氧基-8 | Flomoxef; (-)-(6R,7R)-7-(2-((Difluoromethyl)thio)acetamido)-3-(((1-(2-hydroxyethyl)-1H-tetrazol-5-yl)thio)methyl)-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | C15H18F2N6O7S2 | 详情 | 供应商 | |
110683-22-2 | 8-氨基-2-(1H-四唑-5-基)-4H-1-苯并吡喃-4-酮 | 8-Amino-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-4-one; 8-Amino-4-oxo-2-(tetrazol-5-yl)-4H-1-benzopyran | C10H7N5O2 | 详情 | 供应商 | |
138402-11-6 | 厄贝沙坦; 2-丁基-3-[4-[2-(1H-四唑-5-基)苯基]苄基]-1,3-二氮杂螺-[4.4]壬-1-烯-4-酮 | Irbesartan; 3-Butyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,4-diazaspiro[4.4]non-3-en-1-one | C25H28N6O | 详情 | 供应商 | |
139481-59-7 | 坎地沙坦; 2-乙氧基-3-[[4-[2-(1H-四唑-5-基)苯基]苯基]甲基]-3H-苯并咪唑-4-羧酸 | Candesartan; 2-Ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]-3H-benzoimidazole-4-carboxylic acid | C24H20N6O3 | 详情 | 供应商 | |
139481-72-4 | 三苯甲基坎地沙坦; 2-乙氧基-3-[[4-[2-(1-三苯甲基-1H-四唑-5-基)苯基]苯基]甲基]-3H-苯并咪唑-4-羧酸 | Trityl candesartan; 2-Ethoxy-1-[[(2'-(1-triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl]benzimidazole-7-carboxylic acid | C43H34N6O3 | 详情 | 供应商 | |
189400-21-3 | 4-(1-羟基-1-甲基乙基)-2-丙基-1-[[2'-[三苯甲基-1H-四唑-5-基][1,1'-联苯]-4-基]甲基]-1H-咪唑-5-甲酸乙酯 | 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-; Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[(‘2-1H-tetrazol-5-ylbiphenyl-4-yl); 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2’-[(triphenylmethyl)-1H-tetrazol-5-yl][1,1’-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid ethyl ester | C45H44N6O3 | 详情 | 供应商 | |
247257-48-3 | 非马沙坦; 2-丁基-5-二甲基氨基硫代甲酰甲基-6-甲基-3-[[2'-(1H-四唑-5-基)联苯-4-基]甲基]嘧啶-4(3H)-酮 | Fimasartan; 2-Butyl-5-dimethylaminothiocarbonylmethyl-6-methyl-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]pyrimidin-4(3H)-one | C27H31N7OS | 详情 | 供应商 | |
51599-31-6 | 4-[(1-乙基-1H-四唑-5-基)硫代]-1-羟基-N-[2-(十四烷基氧)苯基]-2-萘甲酰胺 | 4-[(1-ethyl-1H-tetrazol-5-yl)thio]-1-hydroxy-N-[2-(tetradecyloxy)phenyl]-2-Naphthalenecarboxamide; 1-Hydroxy-4-(1-ethyl-5-tetrazolylthio)-2-(2'-tetradecyloxy)naphthanilide | C34H45N5O3S | 详情 | 供应商 | |
69372-19-6 | 吡嘧司特; 吡嘧司特; 9-甲基-3-(1H-四唑-5-基)-4H-吡啶并[1,2-Α]嘧啶-4-酮; 哌罗司特 | 4H-Pyrido[1,2-a]pyrimidin-4-one,9-methyl-3-(2H-tetrazol-5-yl)-; 4H-Pyrido[1,2-a]pyrimidin-4-one,9-methyl-3-(1H-tetrazol-5-yl)- (9CI); 9-Methyl-3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one; Pemirolast | C10H8N6O | 详情 | 供应商 | |
92636-39-0 | (6R,7S)-7-[(S)-2-[(2-氨基-2-羧乙基)硫]乙酰氨基]-7-甲氧基-3-[(1-甲基-1H-四唑-5-基)硫]甲基]-8-氧代-5-? | CEFMINOX SODIUM; (6R,7S)-7-[[[[(2S)-2-Amino-2-carboxyethyl]thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt; Cefminox sodium | C16H19N7Na2O7S3 | 详情 | 供应商 | |
139481-69-9 | 2-乙氧基-1-[[(2'-(1H-四唑-5-基)联苯-4-基)甲基]苯并咪唑]-7-甲酸乙酯; 2-乙氧基-1-[[(2'-(1H-四唑-5-基)联 | Ethyl-2-Ethoxy-1-[[(2'-(1h-Tetrazol-5-Yl)Biphenyl-4-Yl)Methyl]Benzimidazole]-7-Carboxylate; Ethyl-2-Ethoxy-1-[[(2'-(1h-Tetrazol-5-Yl)Biphenyl-4-Yl)Methyl]Benzimidazole]-7-Carboxylate; ETHYL2-ETHOXY-1-[[2'-(1H-TETRAZOL-5-YL)METHYL]BENZIMIDAZOLE-7-CARBOXYLATE; Candesartan Methyl Ester; thyl-2-ethoxy-1-[[2'-(1Htetrazol-5-yl-)methyl]benzimidazole]-7-carboxylate | C26H24N6O3 | 详情 | 供应商 | |
380380-63-2 | 特地唑胺中间体异构体; 特地唑胺中间体异构体; 5-溴-2-(1-甲基-1H-四唑-5-基)-吡啶 | 5-BROMO-2-(1-METHYL-1H-TETRAZOL-5-YL)-PYRIDINE
; REF DUPL: 5-Bromo-2-(1-methyl-1H-tetrazol-5-yl)-pyridine; Pyridine, 5-broMo-2-(1-Methyl-1H-tetrazol-5-yl)- | C7H6BrN5 | 详情 | 供应商 |